Earlier this year, the researchers published their findings
in ACS Central Science, a journal of the American Chemical Society, and
now are working to develop a library of relevant PG fragments in a
project supported by a $1.9 million grant from the National Institute of
General Medical Sciences (NIGMS). The new funding will yield data that
will be critical in future development of antibiotics and treatments for
inflammatory disorders and is complementary to the funding Grimes and
her team received to metabolically engineer bacterial cell walls.
"These are the small molecules we should be using,” Grimes said. “And
if these things truly become immune modulators, they could be used in
all kinds of front-line work.”
As an example of the potential gains these new tools provide,
Reinecker said they identified more than 30 genes related to
inflammatory bowel disease that were activated in response to the gut
bacteria fragment the Grimes Lab synthesized.
“It all starts with having sufficient research tools,” he said.
“These components are now in our hands and that is critical for getting
at these pathways…. Once we have the mechanisms, we can interfere with
them. We can block them or enhance them. Now we have components that
will allow us to more precisely understand how the immune system
recognizes bacteria.”
Grimes’ collaboration with Reinecker stems from her days as a
postdoctoral researcher at Harvard with Dr. Daniel K. Podolsky.
Reinecker was establishing his lab at Massachusetts General Hospital at
the time and the two would often talk in the hallway about the missing
tools that immunologists desperately needed.
“This is a beautiful collaboration — chemistry with immunology,” Reinecker said.
Grimes’ students produced the chemical fragments Reinecker’s
immunology lab needed for experiments that simply couldn’t be done with
the simpler “off-the-shelf” MDP probes. Reinecker’s immunology lab, in
turn, gave Grimes’ students insight into how their fundamental science
can provide powerful new possibilities for medical research.
Lead authors Kristen DeMeester and Klare Bersch both earned their
doctorates at UD during this work. DeMeester now is working at Scripps
Research in California and Bersch works as a medicinal chemist at
Prelude Therapeutics in Wilmington, Delaware.
“I’m a synthetic chemist, but I hadn’t done any biological assays
prior to this experience,” DeMeester said. “Now I do a lot of it.
Infecting cells is all I do.”
Both had key roles in this work. DeMeester helped identify the
fragments needed for the work in collaboration with Kimberly
Wodzanowski. Bersch synthesized and characterized them and established
the process for others to use in the lab so future testing can continue.
“You can’t get these from a vendor,” Bersch said. “You have to have a synthetic chemist.”
Once they had synthesized the compounds they wanted to use, they took
them to Reinecker’s lab in Boston (before he moved to Dallas) and
worked with Rachid Zagani there to treat macrophage cells (the cells
that provide immune defense), extract genetic material and test it.
They found exciting things.
“Each fragment we tested had a different signature of genes,” Bersch said. “They were unique responses.”
The immunologists in Reinecker’s lab also got new insights from the project.
“As chemists, we look at the structure of molecules, bonds and
atoms,” DeMeester said. “We’re looking at atomic networks. Immunologists
look at cells in that complex way, in those types of networks. But
they’re looking at cellular protein networks.”
Grimes said making these new molecular probes available will expand
the capacity of researchers to pursue new questions and will surely lead
to new findings.
Having just one primary kind of probe restricted the insight researchers could gain.
Grimes said it reminded her of her daughter’s fondness for the color
pink. It is her “go-to color” in the crayon box. Everything winds up
pink.
“Just as I’m trying to teach my daughter that there is more than one
color in the box to choose and how much more could be represented on the
paper with all of the colors, Christian and I are trying to teach the
immunologists that there is more than one peptidoglycan fragment and
it’s important to use more than one,” Grimes said. “We need to widen our
palette when considering the depth of immunological response around
these fragments.”
DeMeester said it is exciting to be part of such work.
“This really shows the power of collaboration and how great it can
be,” DeMeester said. “The best part of the whole thing for me was seeing
something for the first time that the world hasn’t seen before. I
wouldn’t be the scientist I am without my mentor Catherine Grimes.”
Also participating in the collaborative research were Siavash
Mashayekh and Kimmie Wodzanowski of UD’s Department of Chemistry and
Biochemistry and Shuyuan Chen and Shuzhen Liu, both of the University of
Texas Southwestern Medical Center.
The work was supported by the Delaware COBRE (Centers of Biomedical
Research Excellence) Program with a grant from the National Institute of
General Medical Sciences, by the National Science Foundation and by
grants from the National Institutes of Health.